Skip Navigation
Section Navigation HPA website


 

Hybridoma Detail

Formats Price
£375.00
£525.00
£50.00

Hybridoma Collection: Mc 39-16

Catalogue No.: 89072609
Cell Line Name: Mc 39-16
Reactivity: Anti- A31 idiotype, murine
Antibody Isotype: Rat IgG2a
Fusion Species: Mouse x Rat Heterohybridoma
Myeloma: NS1
Immunological Donor: LOU rat spleen
Immunogen: Sheep anti murine IgM-A31 IgM complexes
Transfected DNA: Not Applicable
Cell Line Description: This heterohybridoma secretes a rat monoclonal antibody against the A-31 idiotype of murine B cell lymphoma. Available for use as a heterohybridoma secreting rat IgG2a antibody. However, use in studies of the A31 tumour requires permission from the originators.
Sub Culture Routine: Maintain cultures between 3-9x100,000 cells/ml; 5% CO2; 37°C.
Culture Medium: DMEM + 2mM glutamine + 10% Foetal Bovine Serum (FBS)
Depositor: Mr H M McBride/Dr M J Glennie, Tenovus, Southampton
Originator: No
Country: UK
References: None Specifed By Depositor
Patent: None Specified by Depositor
Research Council Deposit: No
Release Conditions: No

The HPA Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by HPA Culture Collections are accurate, HPA Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and HPA Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by HPA Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.